About Hexacare Pharmaceuticals
Hexacare Pharmaceuticals is a Healthcare company based in Chennai (India) founded in 2015. Trader and wholesaler of anti-cancer drugs, injections, tablets, and pharmaceutical products. It operates on a B2B model. The company has 21 employees. Its Indian entity Hexacare Pharmaceuticals Private Limited reported revenue of ₹50.05 Cr. Hexacare Pharmaceuticals offers products and services including Hertraz Trastuzumab 150 Mg Injection, Biomus 0.5 mg, Reditux Rituximab 500 Mg Injection, Tenohep 300 Mg 10 Tablets, and Trioday 30 Tablets. Its focus areas include Pharmaceuticals, Oncology, Anti-Cancer Drugs and Nephrology. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Hexacare Pharmaceuticals Private Limited operates as a trader and wholesaler in Chennai, Tamil Nadu, India, specializing in anti-cancer medicines, drugs, injections, tablets, and products for oncology, nephrology, and virology. They distribute branded and generic life-saving medicines through wholesale channels, serving healthcare providers and distributors with a focus on quality and timely supply. The company emphasizes specialized pharmaceutical trading to meet medical needs.
- Headquarters Chennai, India
- Employees 21
- SectorsHealthcare
- Phone•••• ••••
- Website hexacarepharmaceuticals.in
- Legal Name Hexacare Pharmaceuticals Private Limited
- Date of Incorporation 14 Jul, 2015
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹50.05 Cr
FY 2025 · +18% YoY
- Net Profit₹55.5 Lakh
FY 2025 · 1% margin
- EBITDA₹1.30 Cr
FY 2025 · 3% margin
- Employee Count21
Associated legal entities of Hexacare Pharmaceuticals
Hexacare Pharmaceuticals operates through Hexacare Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hexacare Pharmaceuticals Private Limited CIN U51900TN2015PTC101404 | Active | 14 Jul 2015 | Chennai, Tamil Nadu | ₹50.0 Cr | 21 | 6 | View details |
Products & Services of Hexacare Pharmaceuticals
Hexacare Pharmaceuticals offers a comprehensive portfolio of products and services, including Hertraz Trastuzumab 150 Mg Injection, Biomus 0.5 mg, Reditux Rituximab 500 Mg Injection, Tenohep 300 Mg 10 Tablets, and Trioday 30 Tablets.
Injection used for treating cancer patients.
Medication for cancer therapy and management.
Injection for targeted cancer treatment.
Tablets for antiviral and cancer-related applications.
Tablets used in virology and oncology treatments.
Injection for nephrology and related conditions.
Tablets for cancer chemotherapy.
Injection for oncology purposes.
Board of directors of Hexacare Pharmaceuticals Private Limited (Hexacare Pharmaceuticals)
Hexacare Pharmaceuticals Private Limited is the primary company behind Hexacare Pharmaceuticals. The board of Hexacare Pharmaceuticals Private Limited currently have 6 directors; the longest-serving is Sivalingam Aravindh, appointed in 2015.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sivalingam Aravindh DIN 06408282 | Director | 14 Jul 2015 | 11 yrs 3 mo | Hexacare Pharmaceuticals Private Limited |
| Arun Kumar DIN 07205134 | Director | 14 Jul 2015 | 11 yrs 3 mo | Hexacare Pharmaceuticals Private Limited |
| Palani Purushothaman DIN 07205136 | Director | 14 Jul 2015 | 11 yrs 3 mo | Hexacare Pharmaceuticals Private Limited |
| Prasad Kumar DIN 07205137 | Director | 14 Jul 2015 | 11 yrs 3 mo | Hexacare Pharmaceuticals Private Limited |
| Balan Dineshkumar DIN 07205139 | Director | 14 Jul 2015 | 11 yrs 3 mo | Hexacare Pharmaceuticals Private Limited |
| Arunkumar DIN 07205140 | Director | 14 Jul 2015 | 11 yrs 3 mo | Hexacare Pharmaceuticals Private Limited |
Financials of Hexacare Pharmaceuticals
Figures of Hexacare Pharmaceuticals Private Limited, the primary company behind Hexacare Pharmaceuticals, for FY 2025. Revenue was ₹50.05 Cr (+18% year on year). Net profit was ₹55.5 Lakh (1% margin). EBITDA was ₹1.30 Cr (3% margin). Revenue has grown at a compounded annual rate of +19% over three years and +19% over five years.
- ₹50.05 CrRevenue · FY 2025 · +18% YoY
- ₹55.5 LakhNet profit · 1% margin
- ₹1.30 CrEBITDA · 3% margin
- ₹18 LakhPaid-up capital
- 21Employees (provident fund records)
- +19%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Hexacare Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Hexacare Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Hexacare Pharmaceuticals
Hexacare Pharmaceuticals has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Hexacare Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hexacare Pharmaceuticals
Hexacare Pharmaceuticals was founded in 2015.
Hexacare Pharmaceuticals is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Hexacare Pharmaceuticals has 21 employees.
The primary company behind Hexacare Pharmaceuticals, Hexacare Pharmaceuticals Private Limited, reported revenue of ₹50.05 Cr for FY 2025, up 18% year on year.
Hexacare Pharmaceuticals Private Limited operates as a trader and wholesaler in Chennai, Tamil Nadu, India, specializing in anti-cancer medicines, drugs, injections, tablets, and products for oncology, nephrology, and virology. They distribute branded and generic life-saving medicines through wholesale channels, serving healthcare providers and distributors with a focus on quality and timely supply. The company emphasizes specialized pharmaceutical trading to meet medical needs.
Hexacare Pharmaceuticals's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Hexacare Pharmaceuticals offers Hertraz Trastuzumab 150 Mg Injection, Biomus 0.5 mg, Reditux Rituximab 500 Mg Injection, Tenohep 300 Mg 10 Tablets, and 4 more products and services.
Hexacare Pharmaceuticals operates through Hexacare Pharmaceuticals Private Limited.
The legal entities of Hexacare Pharmaceuticals currently have 6 directors, including Sivalingam Aravindh, Arun Kumar, Palani Purushothaman and others.